Settlement reached late last night in Risperdal whistle-blower litigation
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, will pay $158 million to settle litigation filed by the state of Texas and a whistleblower over allegedly false marketing of the anti-psychotic drug Risperdal for Medicaid patients.
View full post on Law.com – Newswire
last, late, litigation, Night, Reached, Risperdal, settlement, whistleblower